Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?

Gottlieb SL, Berman SM, Low N.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S156-67. doi: 10.1086/652396. Review.

PMID:
20470051
2.

Chlamydia trachomatis: impact on human reproduction.

Paavonen J, Eggert-Kruse W.

Hum Reprod Update. 1999 Sep-Oct;5(5):433-47. Review.

PMID:
10582782
3.

Risk of sequelae after Chlamydia trachomatis genital infection in women.

Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S134-55. doi: 10.1086/652395. Review.

PMID:
20470050
4.

Screening for chlamydial infection.

Nelson HD, Helfand M.

Am J Prev Med. 2001 Apr;20(3 Suppl):95-107. Review.

PMID:
11306238
5.

Effectiveness of chlamydia screening: systematic review.

Low N, Bender N, Nartey L, Shang A, Stephenson JM.

Int J Epidemiol. 2009 Apr;38(2):435-48. doi: 10.1093/ije/dyn222. Epub 2008 Dec 5. Review.

PMID:
19060033
6.

Developments in the screening for Chlamydia trachomatis: a review.

Kohl KS, Markowitz LE, Koumans EH.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. Review.

PMID:
14719842
7.

Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.

van Valkengoed IG, Postma MJ, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.

Sex Transm Infect. 2001 Aug;77(4):276-82.

8.

Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.

van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.

Int J Epidemiol. 2004 Apr;33(2):416-25. Review.

PMID:
15082651
9.
10.

Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.

Hu D, Hook EW 3rd, Goldie SJ.

Ann Intern Med. 2004 Oct 5;141(7):501-13. Erratum in: Ann Intern Med. 2004 Nov 2;141(9):744.

PMID:
15466767
11.

Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.

Land JA, Van Bergen JE, Morré SA, Postma MJ.

Hum Reprod Update. 2010 Mar-Apr;16(2):189-204. doi: 10.1093/humupd/dmp035. Epub 2009 Oct 14. Review.

PMID:
19828674
12.

Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.

Gottlieb SL, Xu F, Brunham RC.

Sex Transm Dis. 2013 Feb;40(2):97-102. doi: 10.1097/OLQ.0b013e31827bd637. Review.

PMID:
23324973
13.
14.

Female genital Chlamydia trachomatis infection: where are we heading?

Mylonas I.

Arch Gynecol Obstet. 2012 May;285(5):1271-85. doi: 10.1007/s00404-012-2240-7. Epub 2012 Feb 19. Review.

PMID:
22350326
15.

[Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].

Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Coutinho RA, Jager JC.

Ned Tijdschr Geneeskd. 1999 Mar 27;143(13):677-81. Dutch.

PMID:
10321301
16.
17.

Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics.

Mayaud P, Grosskurth H, Changalucha J, Todd J, West B, Gabone R, Senkoro K, Rusizoka M, Laga M, Hayes R, et al.

Bull World Health Organ. 1995;73(5):621-30.

18.

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.

Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M; Chlamydia Screening Studies Project Group.

Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165. Review.

19.

Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.

Howell MR, Quinn TC, Brathwaite W, Gaydos CA.

Sex Transm Dis. 1998 Feb;25(2):108-17.

PMID:
9518379
20.

Update on Chlamydia trachomatis.

Guaschino S, De Seta F.

Ann N Y Acad Sci. 2000;900:293-300. Review.

PMID:
10818417

Supplemental Content

Support Center